In Vitro JAK1/2 Inhibition, in Association with Bortezomib and Lenalidomide, Is Comparable with Bortezomib, Lenalidomide and Dexametasone: An Alternative for Multiple Myeloma Patients with JAK2 overexpression?

Advanced search

Search - Use quotation marks to get a more specific result

Index

Field of knowledge

Start date

Betweenand

Full text
Author(s):	de Oliveira, Mariana Bleker ; Alves, Veruska Lia Fook ; Eugenio, Angela Isabel ; Fernando, Rodrigo Carlini ; Yamamoto, Mihoko ; Colleoni, Gisele W. B. Total Authors: 6
Document type:	Journal article
Source:	Blood; v. 128, n. 22, p. 3-pg., 2016-12-02.

FAPESP's process:	10/17668-6 - Identification of biomarkers and possible therapeutical targets in B-cell lymphoproliferative disorders
Grantee:	Gisele Wally Braga Colleoni
Support Opportunities:	Research Projects - Thematic Grants